Sema4C modulates the migration of primary tumor‑associated lymphatic endothelial cells via an ERK‑mediated pathway

Peng,Jin; Liu,Xijiang; Li,Chengcheng; Gao,Min; Wang,Hongyan

doi:10.3892/etm.2021.10535

Sema4C modulates the migration of primary tumor‑associated lymphatic endothelial cells via an ERK‑mediated pathway

Authors:
- Jin Peng
- Xijiang Liu
- Chengcheng Li
- Min Gao
- Hongyan Wang
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250001, P.R. China, Department of Anesthesiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China
Published online on: August 2, 2021 https://doi.org/10.3892/etm.2021.10535
Article Number: 1102
Copyright: © Peng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Although lymphatic endothelial cells (LECs) serve a positive role in tumor lymphatic metastasis, the regulation of LECs undergoing migration similar to that of tumor cells remains poorly understood. A previous study revealed that semaphorin 4C (Sema4C) could be a marker of LECs in cervical cancer. Thus, the present study aimed to understand the mechanism via which Sema4C could promote the development of tumor‑associated characteristics in LECs in cervical cancer. Primary tumor‑associated LECs (TLECs) were distinguished from cervical cancer by flow cytometry. The promigratory ability was assessed using the Transwell assay. Lentivirus infection was used to alter the expression of Sema4C in TLECs. Confocal laser scanning was used to determine the infection efficiency of lentivirus infection. Sema4C/ERK/E‑cadherin pathway was measured by reverse transcription‑quantitative PCR and western blotting. The co‑localization of Sema4C and the lymphatic marker lymphatic vessel endothelial hyaluronan receptor 1 was verified. Primary tumor‑associated LECs (TLECs) were isolated from a mouse xenograft cervical tumor model. It was revealed that overexpressing Sema4C stimulated the migratory ability of TLECs, downregulated E‑cadherin expression and stimulated ERK phosphorylation, whereas knocking down Sema4C had the opposite effects. The treatment of PD98059 (ERK inhibitor) blocked the pro‑migratory ability of TLECs, which indicated a dependence on the ERK signaling pathway. It was identified that the Sema4C/ERK/E‑cadherin pathway may be critical for the migration of TLECs, which may promote lymph node metastasis. Therefore, Sema4C could be a promising target for the treatment of cervical cancer with lymphatic metastasis.

View Figures

View References

1	Frumovitz M: Sentinel lymph node biopsy for cervical cancer patients-what's it gonna take? Gynecol Oncol. 144:3–4. 2017.PubMed/NCBI View Article : Google Scholar
2	Li H, Wu X and Cheng X: Advances in diagnosis and treatment of metastatic cervical cancer. J Gynecol Oncol. 27(e43)2016.PubMed/NCBI View Article : Google Scholar
3	Hoshino A and Lyden D: Metastasis: Lymphatic detours for cancer. Nature. 546:609–610. 2017.PubMed/NCBI View Article : Google Scholar
4	Lucas ED and Tamburini BAJ: Lymph node lymphatic endothelial cell expansion and contraction and the programming of the immune response. Front Immunol. 10(36)2019.PubMed/NCBI View Article : Google Scholar
5	Saito A: EMT and EndMT: Regulated in similar ways? J Biochem. 153:493–495. 2013.PubMed/NCBI View Article : Google Scholar
6	Kourtidis A, Lu R, Pence LJ and Anastasiadis PZ: A central role for cadherin signaling in cancer. Exp Cell Res. 358:78–85. 2017.PubMed/NCBI View Article : Google Scholar
7	Wang SH, Chang JS, Hsiao JR, Yen YC, Jiang SS, Liu SH, Chen YL, Shen YY, Chang JY and Chen YW: Tumour cell-derived WNT5B modulates in vitro lymphangiogenesis via induction of partial endothelial-mesenchymal transition of lymphatic endothelial cells. Oncogene. 36:1503–1515. 2017.PubMed/NCBI View Article : Google Scholar
8	Lee HR, Li F, Choi UY, Yu HR, Aldrovandi GM, Feng P, Gao SJ, Hong YK and Jung JU: Deregulation of HDAC5 by viral interferon regulatory factor 3 plays an essential role in Kaposi's sarcoma-associated herpesvirus-induced lymphangiogenesis. mBio. 9:e02217–17. 2018.PubMed/NCBI View Article : Google Scholar
9	Jiang L, Hao C, Li Z, Zhang P, Wang S, Yang S, Wei F and Zhang J: miR-449a induces EndMT, promotes the development of atherosclerosis by targeting the interaction between AdipoR2 and E-cadherin in Lipid Rafts. Biomed Pharmacother. 109:2293–2304. 2019.PubMed/NCBI View Article : Google Scholar
10	Wu H, Wang X, Liu S, Wu Y, Zhao T, Chen X, Zhu L, Wu Y, Ding X, Peng X, et al: Sema4C participates in myogenic differentiation in vivo and in vitro through the p38 MAPK pathway. Eur J Cell Biol. 86:331–344. 2007.PubMed/NCBI View Article : Google Scholar
11	Elder AM, Tamburini BAJ, Crump LS, Black SA, Wessells VM, Schedin PJ, Borges VF and Lyons TR: Semaphorin 7A promotes macrophage-mediated lymphatic remodeling during postpartum mammary gland involution and in breast cancer. Cancer Res. 78:6473–6485. 2018.PubMed/NCBI View Article : Google Scholar
12	Acker DWM, Wong I, Kang M and Paradis S: Semaphorin 4D promotes inhibitory synapse formation and suppresses seizures in vivo. Epilepsia. 59:1257–1268. 2018.PubMed/NCBI View Article : Google Scholar
13	Sakurai A, Doci CL and Gutkind JS: Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer. Cell Res. 22:23–32. 2012.PubMed/NCBI View Article : Google Scholar
14	Doçi CL, Mikelis CM, Lionakis MS, Molinolo AA and Gutkind JS: Genetic identification of SEMA3F as an antilymphangiogenic metastasis suppressor gene in head and neck squamous carcinoma. Cancer Res. 75:2937–2948. 2015.PubMed/NCBI View Article : Google Scholar
15	Nasarre P, Gemmill RM and Drabkin HA: The emerging role of class-3 semaphorins and their neuropilin receptors in oncology. Onco Targets Ther. 7:1663–1687. 2014.PubMed/NCBI View Article : Google Scholar
16	Wei JC, Yang J, Liu D, Wu MF, Qiao L, Wang JN, Ma QF, Zeng Z, Ye SM, Guo ES, et al: Tumor-associated lymphatic endothelial cells promote lymphatic metastasis by highly expressing and secreting SEMA4C. Clin Cancer Res. 23:214–224. 2017.PubMed/NCBI View Article : Google Scholar
17	Albini A, Mirisola V and Pfeffer U: Metastasis signatures: Genes regulating tumor-microenvironment interactions predict metastatic behavior. Cancer Metastasis Rev. 27:75–83. 2008.PubMed/NCBI View Article : Google Scholar
18	Olmeda D, Cerezo-Wallis D, Riveiro-Falkenbach E, Pennacchi PC, Contreras-Alcalde M, Ibarz N, Cifdaloz M, Catena X, Calvo TG, Cañón E, et al: Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine. Nature. 546:676–680. 2017.PubMed/NCBI View Article : Google Scholar
19	Young YK, Bolt AM, Ahn R and Mann KK: Analyzing the tumor microenvironment by flow cytometry. Methods Mol Biol. 1458:95–110. 2016.PubMed/NCBI View Article : Google Scholar
20	Lukacs-Kornek V: The role of lymphatic endothelial cells in liver injury and tumor development. Front Immunol. 7(548)2016.PubMed/NCBI View Article : Google Scholar
21	Faustino-Rocha A, Oliveira PA, Pinho-Oliveira J, Teixeira-Guedes C, Soares-Maia R, da Costa RG, Colaço B, Pires MJ, Colaço J, Ferreira R and Ginja M: Estimation of rat mammary tumor volume using caliper and ultrasonography measurements. Lab Anim (NY). 42:217–224. 2013.PubMed/NCBI View Article : Google Scholar
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
23	Humbert M, Hugues S and Dubrot J: Shaping of peripheral T cell responses by lymphatic endothelial cells. Front Immunol. 7(684)2016.PubMed/NCBI View Article : Google Scholar
24	Ji RC: Lymph nodes and cancer metastasis: New perspectives on the role of intranodal lymphatic sinuses. Int J Mol Sci. 18(51)2016.PubMed/NCBI View Article : Google Scholar
25	Potenta S, Zeisberg E and Kalluri R: The role of endothelial-to-mesenchymal transition in cancer progression. Br J Cancer. 99:1375–1379. 2008.PubMed/NCBI View Article : Google Scholar
26	Cho JG, Lee A, Chang W, Lee MS and Kim J: Endothelial to mesenchymal transition represents a key link in the interaction between inflammation and endothelial dysfunction. Front Immunol. 9(294)2018.PubMed/NCBI View Article : Google Scholar
27	Harris AR, Perez MJ and Munson JM: Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression. BMC Cancer. 18(718)2018.PubMed/NCBI View Article : Google Scholar
28	Mumblat Y, Kessler O, Ilan N and Neufeld G: Full-length semaphorin-3C Is an inhibitor of tumor lymphangiogenesis and metastasis. Cancer Res. 75:2177–2186. 2015.PubMed/NCBI View Article : Google Scholar
29	Lawson CD and Ridley AJ: Rho GTPase signaling complexes in cell migration and invasion. J Cell Biol. 217:447–457. 2018.PubMed/NCBI View Article : Google Scholar
30	Lee G, Kim HJ and Kim HM: RhoA-JNK regulates the E-cadherin junctions of human gingival epithelial cells. J Dent Res. 95:284–291. 2016.PubMed/NCBI View Article : Google Scholar
31	Connor AL, Kelley PM and Tempero RM: Lymphatic endothelial lineage assemblage during corneal lymphangiogenesis. Lab Invest. 96:270–282. 2016.PubMed/NCBI View Article : Google Scholar
32	Hou WH, Liu IH, Tsai CC, Johnson FE, Huang SS and Huang JS: CRSBP-1/LYVE-1 ligands disrupt lymphatic intercellular adhesion by inducing tyrosine phosphorylation and internalization of VE-cadherin. J Cell Sci. 124:1231–1244. 2011.PubMed/NCBI View Article : Google Scholar
33	Zhou QD, Ning Y, Zeng R, Chen L, Kou P, Xu CO, Pei GC, Han M and Xu G: Erbin interacts with Sema4C and inhibits Sema4C-induced epithelial-mesenchymal transition in HK2 cells. J Huazhong Univ Sci Technolog Med Sci. 33:672–679. 2013.PubMed/NCBI View Article : Google Scholar
34	Marchese V, Juarez J, Patel P and Hutter-Lobo D: Density-dependent ERK MAPK expression regulates MMP-9 and influences growth. Mol Cell Biochem. 456:115–122. 2019.PubMed/NCBI View Article : Google Scholar
35	Tang FY, Chiang EP, Chung JG, Lee HZ and Hsu CY: S-allylcysteine modulates the expression of E-cadherin and inhibits the malignant progression of human oral cancer. J Nutr Biochem. 20:1013–1020. 2009.PubMed/NCBI View Article : Google Scholar
36	Kawata K, Yugi K, Hatano A, Kokaji T, Tomizawa Y, Fujii M, Uda S, Kubota H, Matsumoto M, Nakayama KI and Kuroda S: Reconstruction of global regulatory network from signaling to cellular functions using phosphoproteomic data. Genes Cells. 24:82–93. 2019.PubMed/NCBI View Article : Google Scholar
37	Wick N, Saharinen P, Saharinen J, Gurnhofer E, Steiner CW, Raab I, Stokic D, Giovanoli P, Buchsbaum S, Burchard A, et al: Transcriptomal comparison of human dermal lymphatic endothelial cells ex vivo and in vitro. Physiol Genomics. 28:179–192. 2007.PubMed/NCBI View Article : Google Scholar